Agarwal, N., Schweizer, M. T., Castro, E., Azad, A., George, D. J., Chakrabarti, J., Narayanan, S., Tang, Y., Fizazi, K. (2025). Mevrometostat in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with abiraterone acetate: The phase 3, randomized MEVPRO-1 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps5113